Abbisko will debut two blockbuster clinical research results at the 2023 European Society for Medical Oncology(ESMO) ...Middle East

PR Newswire - News
Abbisko will debut two blockbuster clinical research results at the 2023 European Society for Medical Oncology(ESMO)
SHANGHAI, Oct. 16, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter) announced that the clinical results of first-in-human study of FGFR4 inhibitor Irpagratinib(ABSK011)and the clinical results of first-in-human dose-escalating of PD-L1 inhibitor...

Hence then, the article about abbisko will debut two blockbuster clinical research results at the 2023 european society for medical oncology esmo was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Abbisko will debut two blockbuster clinical research results at the 2023 European Society for Medical Oncology(ESMO) )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News